RWE/ Studies - TPValue

Life Science

Medical Affairs

RWE/ Studies

Evidence of safety, efficacy and value is needed to successfully achieve market access and product acceptance. In addition to robust early development clinical trial programs, payers, patients, physicians and caregivers demand evidence of benefits and risks in a real-world environment. Once marketed, product insights from real-world data are essential to confirming and updating your market strategy.

TPValue International multidisciplinary team offers a series of solutions suited to the purpose of addressing your most challenging research questions. Where appropriate, we also consider the therapeutic expertise and clinical development experience in our team to perform hybrid retrospective and prospective studies.

When designing and executing studies, we leverage TPValue International multidisciplinary team of researchers and evidence generation strategists to leverage relevant real-world data and high-quality patient-centric data. Our intervention team leverages the achievement and use of patient-centered outcomes. Our database has numerous Patient Reported Experience Measures (PREMs) and Patient Reported Outcome Measures (PROMs) tools and instruments ready to be used in research or even management.